Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors

Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors - Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021034

Enrollment

Registered

2016-02-15

Start date

2014-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial vaginosis

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients receiving trans-vaginal chloramphenicol during pregnancy for bacterial vaginosis 2.Patients receiving written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients discontinued trans-vaginal chloramphenicol 2.Patients having severe kidney dysfunction or liver dysfunction

Design outcomes

Primary

Measure	Time frame
Maternal plasma concentration of chloramphenicol	—

Secondary

Measure	Time frame
Factors determining the plasma exposure of chloramphenicol Effect of maternal plasma concentration of chloramphenicol on her infants	—

Countries

Japan

Contacts

Public ContactTakafumi Naito

Hamamatsu University School of Medicine Department of Hospital Pharmacy

Pharmacyham-adm@umin.ac.jp053-435-2623

Outcome results